Not available
Quote | TRACON Pharmaceuticals Inc. (NASDAQ:TCON)
Last: | $1.85 |
---|---|
Change Percent: | 0.0% |
Open: | $1.82 |
Close: | $1.85 |
High: | $1.956 |
Low: | $1.82 |
Volume: | 54,899 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | TRACON Pharmaceuticals Inc. (NASDAQ:TCON)
2024-04-18 08:15:07 ET Losers: Lithium Americas Corp LAC -24% on plans for 55M-share offering . NRX Pharmaceuticals NRXP -22% announces proposed underwritten public offering of common stock . Canaan CAN -22% files for $300M mixed shelf offering . Ic...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 62.9% to $0.0373 on volume of 466,310,671 shares INVO BioScience Inc. (INVO) rose 139.5% to $1.82 on volume of 225,666,770 shares PROSHARES TRUST (SQQQ) rose 3.7% to $11.86 on volume of 167,545,988 ...
Message Board Posts | TRACON Pharmaceuticals Inc. (NASDAQ:TCON)
Subject | By | Source | When |
---|---|---|---|
Bid 50 cent. | willlbone | investorshub | 04/26/2023 4:07:40 PM |
whytestocks: $TCON News Article - Runway Growth Finance Corp. Provides First Quarter 2023 Portfolio | whytestocks | investorshangout | 04/06/2023 12:40:46 PM |
Update: Arbitration decision likely in April. | Tartiaboy | investorshub | 04/04/2023 5:30:03 PM |
Major arbitration decision imminent. | Tartiaboy | investorshub | 03/30/2023 1:19:10 PM |
What do you think happens | shurtha2000 | investorshub | 03/30/2023 12:49:56 PM |
News, Short Squeeze, Breakout and More Instantly...
TRACON Pharmaceuticals Inc. Company Name:
TCON Stock Symbol:
NASDAQ Market:
TRACON Pharmaceuticals Inc. Website:
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. Travelers repo...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 62.9% to $0.0373 on volume of 466,310,671 shares INVO BioScience Inc. (INVO) rose 139.5% to $1.82 on volume of 225,666,770 shares PROSHARES TRUST (SQQQ) rose 3.7% to $11.86 on volume of 167,545,988 ...
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the P...